Zymeworks ZYME Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.
The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's additional paid-in capital?
- Zymeworks (ZYME) reported additional paid-in capital of $107.53M in Q1 2026.
- How has Zymeworks's additional paid-in capital changed year-over-year?
- Zymeworks's additional paid-in capital decreased by 30.3% year-over-year, from $154.22M to $107.53M.
- What is the long-term trend for Zymeworks's additional paid-in capital?
- Over 4 years (2021 to 2025), Zymeworks's additional paid-in capital has grown at a -12.7% compound annual growth rate (CAGR), from $197.71M to $114.63M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.